Product How it works Pricing Blog FAQ About Contact
Phathom Pharmaceuticals

Phathom Pharmaceuticals (NASDAQ: PHAT) revenue

Phathom Pharmaceuticals reported revenue of $175.1m for fiscal 2025, 216.9% more than in fiscal 2024 ($55.3m).

Phathom Pharmaceuticals has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 4 fiscal years on record.

Revenue, in millions of US dollars0.020220.7202355.32024175.12025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$175.1m+216.9%−$160.0m−91.4%
2024$55.3m+8,001.5%−$277.5m−502.2%
2023$0.7m—−$167.3m−24,532.6%
2022$0.0m—−$172.4m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Phathom Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Phathom Pharmaceuticals ranks 255th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Phathom Pharmaceuticals, 216.9%.

RankCompanyRevenueRevenue growth
253rdMaravai LifeSciences$185.7m−28.3%
254thStoke Therapeutics$184.4m404.5%
255thPhathom Pharmaceuticals$175.1m216.9%
256thSyndax Pharmaceuticals$172.4m627.8%
257thRegenxbio$170.4m104.5%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Phathom Pharmaceuticals

How much revenue did Phathom Pharmaceuticals make in fiscal 2025?
Phathom Pharmaceuticals reported revenue of $175.1m for fiscal 2025, compared with $55.3m in fiscal 2024.
What was the best year for revenue at Phathom Pharmaceuticals?
Of its last 4 fiscal years, fiscal 2025, with $175.1m.
Where does Phathom Pharmaceuticals rank in its sector by revenue?
It ranks 255th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Phathom Pharmaceuticals come from?
From the annual report (Form 10-K) that Phathom Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Phathom Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Phathom Pharmaceuticals: the Phathom Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.